Single-Cell Peripheral Immunoprofiling of Lewy Body Disease in a Multi-site Cohort
Thanaphong PhongpreechaiD, Kavita Mathi, Brenna CholertoniD, Eddie J. Fox, Natalia SigaliD, Camilo A. EspinosaiD, S. Momsen ReinckeiD, Philip ChungiD, Ling-Jen Hwang, Chandresh R. GajeraiD, Eloïse BersoniD, Amalia PernaiD, Feng XieiD, Chi-Hung ShuiD, Debapriya HazraiD, Divya Channappa, Jeffrey DunniD, Lucas B. KippiD, Kathleen L. PostoniD, Kathleen S. MontineiD, Holden Terry MaeckeriD, Nima AghaeepouriD, Thomas Jude MontineiD
Abstract
Studies implicated peripheral organs involvement in the development of Lewy body disease (LBD), a spectrum of neurodegenerative diagnoses that include Parkinsons Disease (PD) without or with dementia (PDD) and dementia with Lewy bodies (DLB). This study characterized peripheral immune responses unique to LBD at single-cell resolution. Peripheral mononuclear cell (PBMC) samples were collected from sites across the U.S. The diagnosis groups comprise healthy controls (HC, n=164), LBD (n=132), Alzheimers disease dementia (ADD, n=98), other neurodegenerative disease controls (NDC, n=21), and immune disease controls (IDC, n=14). PBMCs were activated with three stimulants, stained by surface and intracellular signal markers, and analyzed by flow cytometry, generating 1,184 immune features. Our model classified LBD from HC with an AUROC of 0.90{+/-}0.06. The same model distinguished LBD from ADD, NDC, IDC, or other common conditions associated with LBD. Model predictions were driven by pPLC{gamma}2, p38, and pSTAT5 signals from specific cell populations and activations.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 1
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Mapping the peripheral immune landscape of Parkinson's disease patients with single-cell sequencing
Gaël Moquin‐Beaudry, Lovatiana Andriamboavonjy, … Martine Tétreault·BrainPeer-reviewed·Feb 27, 2025
- Profiling peripheral immune cells in Parkinsons disease: A Scoping Review
Sherilyn Junelle Recinto, Janna E. Jernigan, … Jo Anne Stratton·Journal of Parkinson s DiseasePeer-reviewed·Oct 8, 2026
- Network Proteomics of the Lewy Body Dementia Brain Reveals Presynaptic Signatures Distinct from Alzheimer's Disease
Anantharaman Shantaraman, Eric B. Dammer, … Lenora A. Higginbotham·Molecular NeurodegenerationPeer-reviewed·Aug 6, 2024
- Multiplex Proteomics of Lewy Body Dementia Reveals Cerebrospinal Fluid Biomarkers of Clinical and Neuropathological Heterogeneity
Lenora A. Higginbotham, Saima Rathore, … Nicholas T. Seyfried·bioRxiv·Jun 10, 2025
- Evidence for divergent cortical organisation in Parkinsons disease and Lewy Body Dementia
Angeliki Zarkali, George E. C. Thomas, … Rimona Sharon Weil·Nature CommunicationsPeer-reviewed·Nov 25, 2025
- Neuroimaging and plasma biomarker differences and commonalities in Lewy body dementia subtypes
Naomi Hannaway, Angeliki Zarkali, … Rimona Sharon Weil·Alzheimer s & DementiaPeer-reviewed·May 1, 2025